These entrepreneurs, investors and executives are leading the way in developing new pulmonary and respiratory therapies for patients in critical need. We’re grateful for their leadership of the Respiratory Innovation Summit.
CO-CHAIRS
Timothy Watkins, MD, MSc
Executive Director, Clinical Research, Respiratory Disease Area Lead Inflammation/Respiratory Therapeutic Area
Gilead Sciences
ADVISORY BOARD
Erik Folch, MD, MSc
Chief, Complex Chest Disease Center
Massachusetts General Hospital, Harvard Medical School
Irina Petrache, MD
Chief & Professor, Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Health
Michelle Turenne
Chief, Corporate Alliances and Business Development/ Staff, ATS Committee on Drug Device Discovery & Development
American Thoracic Society
Timothy Watkins, MD, MSc
Executive Director, Clinical Research, Respiratory Disease Area Lead Inflammation/Respiratory Therapeutic Area
Gilead Sciences
Lonny Yarmus, DO, MBA FCCP, ATSF
Clinical Chief, Division of Pulmonary & Critical Care
Johns Hopkins University School of Medicine